Wikipedia -WSS

Wikipedia

author：focus 2025-10-01 17:20:42 - browse：2838

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.

Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study. There was also a positive early trend on overall survival, with Susan Galbraith, AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients.

But investors had been hoping for a clearer signal of benefit. Analysts noted that despite the success in progression-free survival, it was not described as a “clinically meaningful” improvement, which, as J.P. Morgan analysts wrote, “we believe the market would have liked to have seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： In his State of the Union, Biden takes clear aim at 'Big Pharma'

WSS

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Millions may soon lose Medicaid when they don't have to

Altering the blood type of lungs raises potential for universal organs for transplants

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

A deep dive into Applied Therapeutics’ data, and questions on Cassava

entertainment

Wikipedia

hotspot

Cancer drug shortages should be causing more outrage

A public health expert passes on football's full body collisions for youths

In Memoriam: Notable people who died in 2023

The problem with charging patients to message their doctors

Hepatitis C has a cure — but many Americans still lack access to it

RSV shot was 90% effective at preventing hospitalizations in kids

In age of alternative facts, a scholarly course on calling out crap

CDC marks new Covid

Jerome Adams on the need for new antivirals for Covid

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

leisure time

RSV shot was 90% effective at preventing hospitalizations in kids

Air quality improving but still lags in Black, Hispanic communities

UnitedHealth quietly bought dozens of outpatient centers

The Readout: Amylyx, Alumis, and Lundbeck drug updates

The thinking behind the controversial eating disorder chatbot Tessa

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

focus

focus

leisure time

hotspot